2013年6月21日

泡期中後期後使用低劑量hCG效果類似傳統排卵針

於濾泡期中後期以後使用低劑量hCG (200iu/d),效果類似傳統排卵針,
可產生不錯誘導排卵COH效果及IVF-ICSI懷孕率,

http://www.ncbi.nlm.nih.gov/pubmed/16084880?dopt=Abstract


 2005 Aug;84(2):394-401.

Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.

Source

Reproductive Endocrinology Center, University of Bologna, Bologna, Italy. marco.filicori@unibo.it

Abstract

OBJECTIVE:

To prove that low-dose hCG alone can be clinically used to replace FSH-containing gonadotropins to complete controlled ovarian hyperstimulation (COH).

DESIGN:

Controlled, prospective, randomized study.

SETTING:

Academic center.

PATIENT(S):

Infertile patients who are candidates for assisted reproduction.

INTERVENTION(S):

Patients received [1] recombinant FSH or hMG throughout COH (group A); [2] ovarian priming with recombinant FSH/hMG followed by low-dose hCG (200 IU/day) alone (group B).

MAIN OUTCOME MEASURE(S):

Medication consumption; daily serum and follicular fluid (FF) measurements of LH, FSH, hCG, E2, P, T, and androstenedione (A); number and size of follicles; intracytoplasmic sperm injection (ICSI) outcome.

RESULT(S):

In group B: [1] duration and dose of recombinant FSH/hMG administration were reduced; [2] preovulatory serum hCG, E2, and T were higher, whereas FSH was lower; [3] FF hCG, E2, T levels, and E2/T, E2/A, and E2/P ratios were higher, whereas A was lower; [4] small but not large preovulatory follicles were reduced; [5] fertilization rates were higher; and [6] serum and FF P levels, and ICSI outcome did not differ.

CONCLUSION(S):

Low-dose hCG alone in the late COH stages: [1] reduced recombinant FSH/hMG consumption whereas ICSI outcome was comparable to traditional COH regimens; [2] stimulated follicle growth and maturation independent of FSH administration; [3] was associated with a reduced number of small preovulatory follicles; [4] did not cause premature luteinization; [5] resulted in a more estrogenic intrafollicular environment.

沒有留言:

張貼留言